#non-Hodgkin's lymphoma

CAR-T Therapy: Lifeline to A Cure?

The overall response rate was 61% for patients treated with the bispecific T-cell engager.

Women with lymphoma who received treatment in the afternoon had lower relapse and mortality rates than those treated earlier in the day.

The Dana-Farber led ALPINE trial looked at the drug in relapsed chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

Immunotherapy leads the way, along with promising breakthroughs for treating leukemia and multiple myeloma.

Customized T-cell treatment is generally safe for people living with HIV, and outcomes are comparable to those of HIV-negative people.

However, lung cancer incidence among HIV-positive people has fallen over the past two decades.

Toby Keith, Robin Roberts, Jeff Bridges and more share their cancer stories.

As the new editor-in-chief of Cancer Health, Trent Straube is honored to amplify stories of survivors, families, advocates and more.

“This is a very treatable cancer,” says Oscar-winning actress Jane Fonda, who will start chemotherapy for non-Hodgkin lymphoma.

A new report stresses the need for better access to health insurance coverage to improve cancer care and outcomes.

“COVID made my cancer look like nothing,” actor Jeff Bridges, famous as the Dude and now starring in “The Old Man,” tells EW.

A new study finds that Medicaid expansion increases survival and reduces health disparities for newly diagnosed patients with cancer.

The personalized CAR-T therapy prolonged cancer remission compared with standard therapy.

Researchers are examining opportunities for immune-modulating approaches to improve outcomes and reduce side effects.

People with blood cancers and those on chemotherapy may not respond adequately to their first two vaccine doses.